(Q44707630)

5 December 2017

title

Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats (English)

1 reference

5 December 2017

2

1 reference

5 December 2017

6

1 reference

5 December 2017

Karsten Buschard

7

0 references

ROBERTO DI MARCO

object named as

Roberto Di Marco

1

0 references

Ferdinando Nicoletti

object named as

Ferdinando Nicoletti

9

1 reference

ORCID Public Data File 2021

author name string

Cinzia Quattrocchi

3

1 reference

5 December 2017

Rosario Musumeci

4

1 reference

5 December 2017

Anna Maria Speciale

5

1 reference

5 December 2017

Klaus Bendtzen

8

1 reference

5 December 2017

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

109

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

266-271

1 reference

Inflammatory Bowel Disease

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Recent developments in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Treatment of chronic endogenous uveitis with fusidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Antidiabetogenic effect of fusidic acid in diabetes prone BB rats: a sex-dependent organ accumulation of the drug is seen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Sodium fusidate in Gillain-Barré syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Sodium fusidate and the cytokine response in an experimental model of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

The effects of fusidic acid on the inflammatory response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900213-4

7 January 2021

10.1016/S1521-6616(03)00213-4

Identifiers

DOI

1 reference

5 December 2017

1 reference